Apsen Farmaceutica S.A.

Quick facts

Marketed products

• Tramal® · Pain Management
  Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and inhibits the reuptake of norepinephrine and serotonin to provide pain relief.

Phase 3 pipeline

• APSCTC · Diabetes
  APSCTC is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
• Toragesic® · Pain management
  Toragesic is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis.

Phase 2 pipeline

• APSTZD 1
  APSTZD 1 is an investigational drug with unknown mechanism of action.
• APSTZD 2
  APSTZD 2 is an investigational drug with unknown mechanism of action.
• APSTZD 3
• APSTZD 4
  APSTZD 4 is an investigational drug with an unknown mechanism of action.
• Ibuflex®
• Ibuvix® - ibuprofen · Oncology
  Inhibits COX-2 enzyme
• Stilnox CR®

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Apsen Farmaceutica S.A. portfolio CI brief
• Apsen Farmaceutica S.A. pipeline updates RSS